The Benchmark Company upgrades Harvard Bioscience Inc. (HBIO) rating to a Buy

Harvard Bioscience Inc.’s filing revealed that its Chief Executive Officer Green James W acquired Company’s shares for reported $0.11 million on Aug 17. In the deal valued at $4.38 per share,25,000 shares were bought. As a result of this transaction, Green James W now holds 2,862,679 shares worth roughly $12.94 million. Then, Green James W […]